Amanote Research
Register
Sign In
Targeting Myeloid Differentiation Using Potent 2Hydroxypyrazolo[1,5a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors
doi 10.1021/acs.jmedchem.8b00373.s002
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitors With Potent and Selective Activity Against the Malaria ParasitePlasmodium Falciparum
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Design and Synthesis of Potent Inhibitors of the Malaria Parasite Dihydroorotate Dehydrogenase
Potent Norovirus Inhibitors Based on the Acyclic Sulfamide Scaffold
Bioorganic and Medicinal Chemistry
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach With Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors
PLoS ONE
Multidisciplinary
Malarial Dihydroorotate Dehydrogenase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Dihydroorotate Dehydrogenase (DHODH)
Science-Business eXchange
Identification of New Human Malaria Parasite Plasmodium Falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening
Plasmodium Falciparum Dihydroorotate Dehydrogenase (PfDHODH)
Science-Business eXchange
New Potent P-Glycoprotein Inhibitors Carrying a Polycyclic Scaffold